Infant with ventricular septal defect pre-op and post-op - Nursing Case Study
Pathophysiology
• Primary mechanism: Ventricular septal defect (VSD) creates an abnormal opening between the left and right ventricles, leading to left-to-right shunting of blood. This causes increased pulmonary blood flow, leading to pulmonary congestion and potential heart failure in infants.
• Secondary mechanism: The increased workload on the right ventricle due to the extra blood flow can result in right ventricular hypertrophy. Over time, this may lead to pulmonary hypertension if left untreated.
• Key complication: Pre-operatively, the infant is at risk for failure to thrive due to decreased systemic cardiac output and increased metabolic demand. Post-operatively, careful monitoring is necessary to ensure effective closure of the defect and to prevent complications such as residual shunts or conduction disturbances.
Patient Profile
Demographics:
6-month-old female, infant
History:
• Key past medical history: Diagnosed with ventricular septal defect (VSD) at birth
• Current medications: Furosemide, Digoxin
• Allergies: No known drug allergies
Current Presentation:
• Chief complaint: Difficulty breathing and poor weight gain
• Key symptoms: Increased respiratory rate, fatigue, sweating during feeding
• Vital signs: Heart rate 160 bpm, Respiratory rate 60 breaths per minute, Blood pressure 70/40 mmHg, Oxygen saturation 88% on room air
Section 1
As the clinical team prepares to manage the 6-month-old female infant with a ventricular septal defect (VSD) pre-operatively, an initial assessment reveals a concerning change in her clinical status. The infant appears more lethargic than during previous assessments, and her respiratory distress has worsened. Her respiratory rate has increased to 68 breaths per minute, and her oxygen saturation has dropped to 84% despite supplemental oxygen at 2 liters per minute. Auscultation of the lungs reveals bilateral crackles, indicating worsening pulmonary congestion. Her weight gain remains suboptimal, as she has only gained 100 grams in the past month, further emphasizing her difficulty thriving in the current state.
Laboratory tests reveal a significant metabolic acidosis with a blood pH of 7.31 and a bicarbonate level of 18 mEq/L, suggesting inadequate perfusion and increased metabolic demand. The infant's potassium level is elevated at 5.8 mEq/L, likely a result of both her diuretic therapy and the underlying cardiac dysfunction. These findings are consistent with a decompensated state of heart failure, necessitating immediate intervention to stabilize her condition before surgical repair of the VSD can be safely performed.
The clinical team initiates an escalation of care, including increasing diuretic support with intravenous furosemide to alleviate pulmonary congestion and adjusting her digoxin dosage to optimize cardiac output. Continuous monitoring of her electrolytes, particularly potassium, is prioritized, and preparations for potential urgent surgical intervention are made if her condition fails to improve. The team must also consider potential complications such as electrolyte imbalances, arrhythmias due to digoxin toxicity, and further respiratory compromise, all of which require vigilant clinical observation and timely intervention.
Section 2
As the clinical team continues to monitor the infant's response to the intensified treatment, there is a notable change in her status. Over the next several hours, despite aggressive diuretic therapy and adjustments to her cardiac medications, the infant's respiratory distress persists. Her respiratory rate remains elevated at 66 breaths per minute, and her oxygen saturation fluctuates between 82% and 86%, indicating persistent hypoxemia. The crackles in her lungs have slightly diminished, suggesting some relief from pulmonary congestion, but the overall respiratory effort remains labored.
New diagnostic results provide further insight into her deteriorating condition. A repeat electrolyte panel shows that her potassium level has increased further to 6.2 mEq/L. This hyperkalemia poses a significant risk for cardiac arrhythmias, especially in the context of digoxin therapy, which can exacerbate the potential for toxicity. Additionally, a follow-up arterial blood gas reveals a pH of 7.29 and bicarbonate level of 17 mEq/L, indicating persistent metabolic acidosis. These findings suggest that despite measures to enhance cardiac output, the infant's perfusion remains inadequate, likely due to the ongoing cardiac dysfunction.
The clinical team faces critical decisions, balancing the need to correct the electrolyte imbalances while avoiding digoxin toxicity. They decide to administer a potassium-binding resin and initiate a low-dose insulin and glucose infusion to facilitate the intracellular shift of potassium. Continuous cardiac monitoring is implemented to detect any arrhythmias early. Given the infant's inadequate response to medical management, the team begins to expedite preparations for surgical intervention, weighing the risks and benefits of proceeding with the VSD repair under her current clinical circumstances. This decision underscores the importance of timely surgical correction in the context of worsening heart failure and the potential for further complications.
Section 3
As the clinical team continues to monitor the infant, they observe new complications that demand immediate attention. Despite the interventions to address hyperkalemia and metabolic acidosis, the infant's condition further deteriorates. Her heart rate becomes irregular, with episodes of bradycardia interspersed with periods of tachycardia, prompting concerns about the onset of cardiac arrhythmias. Continuous cardiac monitoring reveals occasional premature ventricular contractions, indicating the impact of electrolyte imbalances and cardiac stress.
Additionally, the infant's respiratory status shows concerning signs. Her respiratory rate increases to 72 breaths per minute, and her oxygen saturation drops further, ranging between 78% and 82%. Auscultation reveals diminished breath sounds in the lower lobes, raising suspicions of atelectasis or further pulmonary complications. An urgent chest X-ray is ordered, which confirms the presence of bilateral atelectasis and an enlarged cardiac silhouette, reinforcing the need for immediate surgical intervention.
In a bid to stabilize the infant before surgery, the medical team fine-tunes her ventilatory support, increasing the positive end-expiratory pressure (PEEP) to improve alveolar recruitment. They also adjust her medication regimen, carefully titrating her diuretics and cardiac medications to minimize the risk of further electrolyte disturbances. The priority now is to optimize her hemodynamic status and respiratory function to enhance her chances of a successful surgical outcome. The team remains vigilant, recognizing that any delay could exacerbate her heart failure and lead to irreversible complications. This critical juncture underscores the necessity for swift and coordinated action, as the infant's journey toward recovery hinges on the delicate balance of timely medical and surgical interventions.
Section 4
As the medical team continues to monitor the infant, they note a change in her status that requires immediate attention. Despite the adjustments made to her ventilatory support and medication regimen, her oxygen saturation remains persistently low, hovering around 75-78%. Her heart rate becomes increasingly erratic, with frequent episodes of bradycardia dropping to 80 beats per minute, interspersed with rapid tachycardic spikes reaching 190 beats per minute. These fluctuations suggest worsening cardiac instability, likely exacerbated by ongoing electrolyte imbalances and increased myocardial demand.
Lab results return, indicating a significant drop in serum calcium levels to 6.8 mg/dL, which may be contributing to her cardiac arrhythmias and muscle weakness. The team recognizes the need to address this hypocalcemia promptly, given its role in cardiac contractility and rhythm stability. Additionally, her latest blood gas analysis reveals persistent metabolic acidosis with a pH of 7.28 and bicarbonate levels at 18 mEq/L, despite previous interventions. This metabolic derangement reflects her body's struggle to compensate for the underlying cardiac and respiratory compromise.
In response to these findings, the team initiates intravenous calcium gluconate to correct the hypocalcemia and closely monitors her cardiac rhythm for improvements. The respiratory team reevaluates her ventilatory settings, aiming to optimize her oxygenation and CO2 clearance without causing further barotrauma. As they work to stabilize her, discussions with the surgical team intensify, prioritizing the timing of her corrective surgery to prevent further deterioration. The urgency of her situation is clear, and every decision made now is critical in steering her toward a stable preoperative state, crucial for her survival and recovery.
Section 5
In response to the interventions, the medical team closely monitors the infant's status, hoping for signs of stabilization. Initially, there is a modest improvement in her cardiac rhythm following the administration of intravenous calcium gluconate. Her heart rate begins to show fewer fluctuations, with bradycardic episodes becoming less frequent, and tachycardic spikes settling around 160 beats per minute. However, her oxygen saturation remains a concern, only marginally increasing to 80-82%, indicating that respiratory compromise persists despite optimized ventilatory settings.
Further diagnostic evaluations reveal new complicating factors. A repeat echocardiogram identifies an increase in the size of the ventricular septal defect, suggesting a potential for increased left-to-right shunting. This change contributes to the ongoing cardiac instability and exacerbates pulmonary over-circulation, complicating her respiratory management. Concurrently, a chest X-ray shows signs of pulmonary edema, reflecting the increased workload on her heart and the challenges of maintaining effective gas exchange.
Despite these challenges, the team observes a partial correction of the metabolic acidosis, with her pH improving slightly to 7.32 and bicarbonate levels rising to 20 mEq/L. This improvement suggests some success in metabolic compensation, possibly due to the careful balancing of her fluid and electrolyte management. However, the persistence of her respiratory difficulties and the newly identified complications underscore the urgency of advancing to surgical intervention. The interdisciplinary team continues to refine their approach, focusing on stabilizing her as much as possible to optimize her surgical outcomes, while maintaining open communication with her family about the evolving situation and the critical steps ahead.